Randomized study of autologous stem cell transplantation with high-dose melphalan versus high-dose melphalan and bortezomib in patients with MM 60 years or older

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Randomized study of autologous stem cell transplantation with high-dose melphalan versus high-dose melphalan and bortezomib in patients with MM 60 years or older

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.